0001140361-17-039390.txt : 20171024 0001140361-17-039390.hdr.sgml : 20171024 20171024152601 ACCESSION NUMBER: 0001140361-17-039390 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171023 FILED AS OF DATE: 20171024 DATE AS OF CHANGE: 20171024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fuchs Charles S. CENTRAL INDEX KEY: 0001719576 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37587 FILM NUMBER: 171150861 MAIL ADDRESS: STREET 1: C/O CYTOMX THERAPEUTICS, INC. STREET 2: 151 OYSTER POINT BLVD. SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CytomX Therapeutics, Inc. CENTRAL INDEX KEY: 0001501989 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273521219 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650.515.3185 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD. STREET 2: SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc1.xml FORM 4 X0306 4 2017-10-23 0 0001501989 CytomX Therapeutics, Inc. CTMX 0001719576 Fuchs Charles S. C/O CYTOMX THERAPEUTICS, INC. 151 OYSTER POINT BLVD., STE. 400 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (right to buy) 20.04 2017-10-23 4 A 0 28000 0.00 A 2027-10-22 Common Stock 28000 28000 D 1/36th of the shares subject to the option vest on each monthly anniversary measured from October 23, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such vesting date. /s/ Cynthia J. Ladd, as Attorney-in-Fact for Charles S. Fuchs 2017-10-24